TYKERB 250MG TABLET
Form: Tablets
Pack Size: 30 TABLETS
Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)
MRP: ₹10425.00
NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Tykerb 250MG Tablet, 30 tablets, salt lapatinib 250mg. Its MRP stays at Rs 10,425 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 7,942.86. Group: HER2/EGFR tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Hetero, Natco, Neon, Reliance Life Sciences and others. Handling/counselling: take on an empty stomach, at least one hour before or after food. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.